Disclosure: This article contains affiliate links. If you buy through one, we may earn a commission at no extra cost to you. Products are selected on the evidence and on verified review data, never on commission. How we choose products.
Scalp health matters for hair, and the best-selling anti-dandruff ingredient is the one with the weakest evidence. In a six-month trial of 150 men, zinc pyrithione reduced shedding least of three shampoos tested, and slightly reduced hair shaft diameter while the other two increased it.
Which means the bottle most men reach for is the one least likely to help.
The short version
- Scalp inflammation and Malassezia yeast appear to contribute to the inflammatory component of pattern hair loss, which is why scalp treatment is not purely cosmetic.
- In a head-to-head of 150 men over six months, shedding fell 17.3% on ketoconazole, 16.6% on piroctone olamine and 10.2% on zinc pyrithione.
- On hair shaft diameter the order changed: piroctone olamine +7.7%, ketoconazole +5.4%, zinc pyrithione −2.2%.
- A separate six-month trial found 2% ketoconazole improved hair density and anagen follicle proportion almost similarly to 2% minoxidil.
- Salicylic acid removes scale and buildup. It has no evidence for regrowth and should not be sold as if it does.
- Caffeine, biotin and saw palmetto in shampoo form have limited, mixed or no supporting evidence.
- No shampoo stops genetic hair loss on its own. These are adjuncts, not treatments.
What is scalp health?
Scalp health describes the condition of the skin the hair grows from: its barrier function, its sebum balance, its microbial population and its level of inflammation. It matters for hair because the follicle sits inside that skin. Chronic inflammation, fungal overgrowth and heavy buildup all affect the environment a follicle grows in, and in pattern hair loss an inflammatory component is visible in scalp tissue under the microscope.
Does scalp health actually affect hair loss?
Partly, and the relationship is more established than most grooming content suggests.
Pattern hair loss is driven by androgen sensitivity in the follicle, and that remains the primary mechanism. But scalp tissue in androgenetic alopecia also shows a perifollicular inflammatory component, and researchers have proposed that Malassezia, the yeast responsible for dandruff, contributes to it.
That is the reasoning behind treating the scalp at all. You are not growing hair by washing it. You are removing an inflammatory contributor from an environment that is already under pressure.
It also explains the ceiling. Improving scalp health addresses one contributing factor, not the underlying genetic process, which is why nothing in this article substitutes for the treatments that act below the skin.
Which shampoo ingredient has the best evidence?
French researchers compared three shampoos head-to-head in 150 men with dandruff, used two to three times a week for six months.
Hair shedding fell by 17.3% on 1% ketoconazole, 16.6% on 1% piroctone olamine, and 10.2% on 1% zinc pyrithione (Piérard-Franchimont et al., 2002).
Then the second measure, which almost nobody reports. Average hair shaft diameter rose 7.7% on piroctone olamine and 5.4% on ketoconazole, and fell 2.2% on zinc pyrithione.
Zinc pyrithione is the active in most mass-market anti-dandruff shampoo. In this trial it came last on shedding and was the only one associated with thinner hair shafts.
That is a single study and it should be held loosely. It is also the only direct three-way comparison available, and its result runs against what the shelf would tell you.
How good is the ketoconazole evidence really?
Better than any other shampoo ingredient, and weaker than the marketing implies.
The foundational study compared 2% ketoconazole shampoo against unmedicated shampoo and against 2% minoxidil in men with androgenetic alopecia over six months. Hair density and the size and proportion of anagen follicles improved almost similarly under the ketoconazole and minoxidil regimens (Piérard-Franchimont et al., 1998). The ketoconazole group also showed reduced scalp sebum.
Three plausible mechanisms have been proposed: antifungal action against Malassezia, local interference with androgen activity at the scalp, and an anti-inflammatory effect independent of the antifungal one.
The honest caveats are real. Sample sizes are small, there has been no large independent replication, use for hair loss is off-label, and it is unresolved whether shampoo contact time achieves meaningful follicular effect. Treat it as a well-supported adjunct rather than a treatment.
Best-evidenced active
Nizoral Anti-Dandruff Shampoo with 1% Ketoconazole
Why this one.
Ketoconazole is the only
shampoo active with direct trial evidence for hair density in androgenetic alopecia,
and 1% is the concentration used in the 150-man head-to-head comparison. Nizoral is
the long-established formulation at that strength, with a review base large enough
to judge consistency, rather than one of the many generic listings that have appeared
around the ingredient in the last two years.
What to know.
The most consistent
complaint is dryness. A lot of reviewers describe hair feeling coarse or straw-like
afterwards and end up pairing it with a separate conditioner, which is worth budgeting
for. A smaller group found it did not clear their flaking at all, and several noted
dandruff returning quickly once they stopped, which fits what the research says about
this being maintenance rather than a cure. The 7 fl oz bottle is also poor value at
two to three washes a week over six months, so the 14 fl oz version is the better buy
if you plan to stick with it.
What about piroctone olamine?
It is the most underrated ingredient in this category, and on one measure it outperformed ketoconazole.
In the 150-man comparison, piroctone olamine produced the largest increase in hair shaft diameter of the three, at 7.7%, against ketoconazole’s 5.4%. On shedding reduction it came a close second at 16.6% against 17.3%.
It is also gentler than ketoconazole, better tolerated with frequent use, and available over the counter without the same drying complaints.
The reason it is less well known is commercial rather than scientific. Ketoconazole has a strong brand attached to it and a larger body of published work behind it. Piroctone olamine mostly appears as an unglamorous ingredient in European formulations.
On this evidence it is a reasonable alternative, and arguably the better choice if ketoconazole irritates your scalp.
The buying problem.
Piroctone olamine is difficult to purchase at a verifiable strength. The trial used 1%, and almost no product on the shelf states a concentration at all. Of the listings that do, most sit at 0.5% or 0.6%, which is below what was tested. We are not recommending a specific product here for that reason. If you want to try it, check the label for a stated percentage and treat anything that only lists the ingredient as unknown.
Does scalp buildup cause hair loss?
No, and this is worth separating from the rest.
Sebum, dead skin and product residue accumulate on the scalp and can cause itching, flaking and discomfort. Salicylic acid is a keratolytic, meaning it loosens and removes that scale, and it does this job well.
What it does not do is grow hair. There is no evidence that buildup causes androgenetic alopecia or that removing it reverses anything.
The useful framing: buildup is a comfort and hygiene problem with a straightforward solution. It becomes a hair problem only insofar as chronic irritation and scratching damage hair mechanically.
Use a salicylic acid scalp treatment if you have visible flaking or persistent itch. Skip it if you do not.
Which scalp ingredients have no evidence?
Several of the most heavily marketed ones.
Caffeine. Popular in shampoo, with limited and mixed evidence in that form. Contact time on a scalp is measured in minutes, which is the central problem for any shampoo active.
Biotin. Correcting a genuine biotin deficiency helps hair. Deficiency is rare, and supplementing beyond it does nothing. In shampoo form the evidence is essentially absent.
Saw palmetto. Proposed as a natural DHT blocker, with weak and preliminary evidence, particularly topically.
Rosemary oil. Has one frequently cited trial against minoxidil. It is a single study with methodological limitations and has not been replicated at that standard.
None of these are harmful. They are simply being sold with a confidence the research does not support.
What changed recently
An August 2025 network meta-analysis compared over-the-counter treatments for male androgenetic alopecia, which is the first attempt to rank these options against each other systematically rather than one trial at a time. That kind of analysis is what this field has been missing, and it is worth watching as it is replicated.
The broader picture has not shifted. Ketoconazole remains the shampoo active with the strongest evidence, that evidence remains limited by small samples, and no shampoo has been shown to stop genetic hair loss on its own.
What the evidence cannot tell you
The trials are small and old. The two studies underpinning most of this article involved 150 and roughly 40 participants, conducted in the late 1990s and early 2000s. No large independent replication has followed.
Participants had dandruff. Much of this data comes from men with dandruff or seborrheic dermatitis. Whether the same benefit applies to a man with a healthy scalp and pattern hair loss is genuinely unclear.
Shampoo contact time is a real problem. Whether a few minutes of contact achieves meaningful effect at the follicle remains unresolved, and it is the strongest argument against taking these results at face value.
These are adjuncts. Nothing here approaches the evidence base for the treatments that act below the skin. Our piece on the minoxidil timeline covers what a first-line treatment actually looks like.
Common questions
No shampoo has been shown to stop genetic hair loss by itself. Medicated shampoos can reduce inflammation, dandruff-related shedding and irritation, and some show modest improvements in shedding or density. That is adjunct-level benefit, not treatment.
Trials used it two to three times a week over six months. More frequent use has not been shown to work better and increases the likelihood of dryness.
Not bad, but in the one direct three-way comparison, zinc pyrithione reduced shedding least and was associated with a small decrease in shaft diameter. If you are using an anti-dandruff shampoo specifically because you are worried about thinning, the evidence favours ketoconazole or piroctone olamine.
Evidence is limited and mostly from small studies. It is cheap and harmless, which is a different argument from it being supported.
They work through different mechanisms and are commonly used together. The combination has not been trialled systematically, so it is reasonable rather than proven. The same is true of microneedling, where the combination evidence is considerably stronger.
No. Hair shed during washing was already detached. Washing less does not reduce loss, it just collects it elsewhere, and in men with higher sebum production it can make scalp conditions worse.
What to take from this
Scalp health is a real contributor to hair loss and a small one relative to the genetics. Treating it well is worth doing and will not save a hairline on its own.
What the evidence supports is narrow. Ketoconazole has the best data. Piroctone olamine is the underrated alternative and beat it on shaft diameter. Zinc pyrithione, the ingredient in most bottles on the shelf, performed worst on both measures in the only direct comparison available.
Everything else in the category, the caffeine, the biotin, the botanical blends, is being sold considerably ahead of its evidence.
More in our Grooming section.
References
- Piérard-Franchimont, C., et al. (1998). Ketoconazole shampoo: effect of long-term use in androgenic alopecia. Dermatology. [NO LINK]
- Piérard-Franchimont, C., et al. (2002). Nudging hair shedding by antidandruff shampoos: a comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. 150 men, six months. [NO LINK]
- Network meta-analysis of over-the-counter treatments for male androgenetic alopecia (August 2025). MDPI. [NO LINK]
This article summarises published research and is not medical advice. Hair loss has several causes that respond to different treatments. See a doctor or dermatologist for a diagnosis before starting anything.
